Interface Inc (TILE)
NASDAQ
Quarter End | Jan 2023 | Avr 2023 | Juil 2023 | Oct 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 335,56M | 295,79M | 332,08M | 311,01M | 325,12M | 289,74M | 346,64M | 344,27M |
Revenu d'exploitation | -14,59M | 9,48M | 28,91M | 30,99M | 35,15M | 24,45M | 38,15M | 42,18M |
Revenu avant impôt | -24,6M | -528k | 21,12M | 16,12M | 26,94M | 19M | 31,15M | 36,07M |
Revenu net | -24,62M | -714k | 15,8M | 9,88M | 19,56M | 14,18M | 22,56M | 28,44M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -16,45M | 7,98M | 29,44M | 24,28M | 33,75M | 25,42M | 37,32M | 41,94M |
EBITDA | 28,45M | 20,75M | 40,36M | 42,73M | 41,75M | 35,36M | 49,17M | 55,68M |
Fin d'année 31 Décembre 2023 | 2017 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 958,62M | 996,44M | 1,18B | 1,34B | 1,11B | 1,2B | 1,3B | 1,26B |
Revenu d'exploitation | 92,96M | 109,84M | 84,95M | 130,9M | -49,29M | 106,45M | 75,4M | 104,52M |
Revenu avant impôt | 79,14M | 100,54M | 54,99M | 101,82M | -89,42M | 72,63M | 41,92M | 63,65M |
Revenu net | 54,16M | 53,25M | 50,25M | 79,2M | -81,93M | 55,23M | 19,56M | 44,52M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0.418 | 0.427 | 0.402 | 0.639 | -0.66 | 0.444 | 0.158 | 0.361 |
EBIT | 93,29M | 107,67M | 79M | 127,47M | -60,18M | 103,96M | 71,85M | 95,44M |
EBITDA | 123,59M | 140,11M | 127,95M | 178,31M | 124,83M | 153,98M | 152,92M | 145,59M |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales